全文获取类型
收费全文 | 2763172篇 |
免费 | 206461篇 |
国内免费 | 7046篇 |
专业分类
耳鼻咽喉 | 36493篇 |
儿科学 | 90802篇 |
妇产科学 | 75915篇 |
基础医学 | 391801篇 |
口腔科学 | 78123篇 |
临床医学 | 250787篇 |
内科学 | 540749篇 |
皮肤病学 | 63425篇 |
神经病学 | 219692篇 |
特种医学 | 104418篇 |
外国民族医学 | 701篇 |
外科学 | 414748篇 |
综合类 | 66411篇 |
现状与发展 | 14篇 |
一般理论 | 953篇 |
预防医学 | 211110篇 |
眼科学 | 64901篇 |
药学 | 200210篇 |
22篇 | |
中国医学 | 7616篇 |
肿瘤学 | 157788篇 |
出版年
2021年 | 22190篇 |
2019年 | 22793篇 |
2018年 | 32443篇 |
2017年 | 24621篇 |
2016年 | 27525篇 |
2015年 | 31335篇 |
2014年 | 43646篇 |
2013年 | 64087篇 |
2012年 | 87955篇 |
2011年 | 93113篇 |
2010年 | 54941篇 |
2009年 | 51596篇 |
2008年 | 85491篇 |
2007年 | 90538篇 |
2006年 | 91192篇 |
2005年 | 87725篇 |
2004年 | 84150篇 |
2003年 | 80123篇 |
2002年 | 77104篇 |
2001年 | 138992篇 |
2000年 | 142509篇 |
1999年 | 118025篇 |
1998年 | 32538篇 |
1997年 | 28702篇 |
1996年 | 28734篇 |
1995年 | 27494篇 |
1994年 | 25085篇 |
1993年 | 23325篇 |
1992年 | 89816篇 |
1991年 | 86198篇 |
1990年 | 82940篇 |
1989年 | 79603篇 |
1988年 | 72861篇 |
1987年 | 71196篇 |
1986年 | 66694篇 |
1985年 | 63501篇 |
1984年 | 47414篇 |
1983年 | 40120篇 |
1982年 | 23393篇 |
1979年 | 41819篇 |
1978年 | 29112篇 |
1977年 | 24488篇 |
1976年 | 23046篇 |
1975年 | 23966篇 |
1974年 | 29013篇 |
1973年 | 27984篇 |
1972年 | 26064篇 |
1971年 | 23912篇 |
1970年 | 22539篇 |
1969年 | 21015篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
93.
M. Parikh M.D. J. Duncombe M.B. B.S. G.A. Fielding M.D. 《Surgery for obesity and related diseases》2006,2(5):99-522
BACKGROUND: Many mild-to-moderately obese individuals (body mass index [BMI] 30-35 kg/m(2)) have serious diseases related to their obesity. Nonoperative therapy is ineffective in the long term, yet surgery has never been made widely available to this population. METHODS: Between 1996 and 2004, 93 patients with a BMI of 30-35 kg/m(2) underwent laparoscopic adjustable gastric banding with the LAP-BAND. All patients were referred by their primary physician, entered into a comprehensive bariatric surgery program at one Australian center, and operated on by one surgeon. Data on all patients were collected prospectively and entered into an electronic registry. The study parameters included preoperative age, gender, BMI, presence of co-morbidities, percentage of excess weight loss, and resolution of co-morbidities. RESULTS: The mean age was 44.6 years (range 16-76), mean weight was 98 kg, and the mean BMI was 32.7 kg/m(2) (range 30-34). Of the 93 patients, 42 (45%) had co-morbidities, including asthma, diabetes, hypertension, and sleep apnea. The proportion of patients in follow-up was 79%, 85%, and 89% at 1, 2, and 3 years, respectively. The mean weight was reduced to 71 kg at 1 year, 72 kg at 2 years, and 72 kg at 3 years. The mean BMI was reduced to 27.2 +/- 2.2, 27.3 +/- 3.1, and 27.6 +/- 3.7 kg/m(2), respectively, and the mean percentage of excess weight loss was 57.9% +/- 24.5%, 57.6 +/- 29.3%, and 53.8% +/- 32.8% at 1, 2, and 3 years, respectively. At 3 years, the BMI was 18-24 kg/m(2) in 34%, 25-29 kg/m(2) in 51%, and 30-35 kg/m(2) in 10%. At 3 years, the percentage of excess weight loss was <25% in 10%, 25-50% in 24%, 50-75% in 51%, and >75% in 10%. The co-morbidities improved or completely resolved in most patients. No mortality occurred. CONCLUSION: We are very encouraged by this series of low BMI patients treated with the LAP-BAND. Their weight loss has been good, the complications have been minimal, and the co-morbidities have partially or wholly resolved. With additional study, it is reasonable to expect the weight guidelines for bariatric surgery to be altered to include patients with a BMI of 30-35 kg/m(2). 相似文献
94.
The precise molecular cause of insulin resistance has not yet been elucidated. Resistance to the normal action of insulin contributes to the pathogenesis of a number of common human disorders, including type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus, hypertension, and the Metabolic Syndrome X, thus constituting a major public health problem. A disease program aimed at combating this disorder should focus on the identification of targets for therapeutic intervention which may overcome insulin resistance and hence the associated metabolic consequences characteristic of the Metabolic Syndrome. Although the primary defect in the pathogenesis of type 2 diabetes is unknown, genetic and environmental factors are likely to contribute to the manifestation of this progressive metabolic disorder, which is usually not clinically apparent until mid-life. Defects at the level of glucose uptake/phosphorylation characterize insulin resistance in skeletal muscle of type 2 diabetic patients. Identification of putative components of the insulin receptor-signaling pathway may offer insights into mechanisms involved in insulin resistance. Enhanced flux of free fatty acids due to impaired lipid metabolism may contribute to impaired insulin secretion and peripheral insulin resistance. Genes regulating lipolysis are prime candidates for susceptibility towards the metabolic syndrome. Here we describe pathways constituting complex interactions that control glucose homeostasis. We will be considering (1) regulation of glucose uptake by the insulin receptor signaling pathway, and (2) control of adipogenesis and insulin sensitivity by the sterol response element binding protein (SREBP) pathway. 相似文献
95.
96.
97.
皮质发育障碍模型的建立及其致痫敏感性的研究 总被引:1,自引:0,他引:1
目的:建立皮质发育障碍模型,探讨皮质发育障碍模型的敏感性。方法:在SD大鼠孕17d腹腔注入1,3-二氯乙烯-亚硝基脲(BCNU)制作皮质发育障碍模型;Nissl染色观察P60d仔鼠病理变化;选取P60d雄性仔鼠,腹腔注射氯化锂-毛果芸香碱,分别比较两组大鼠癫发生的潜伏期、持续状态时间和死亡率。结果:同龄仔鼠脑组织湿重实验组比对照组显著减轻(P<0.01);Nissl染色显示皮质变薄、皮质层次紊乱、海马区域异位细胞异常聚集;有皮质发育障碍的仔鼠注射氯化锂-毛果芸香碱后,癫发生的潜伏期显著缩短(P<0.01),癫持续状态时间延长(P<0.01),死亡率显著升高(P<0.05)。结论:BCNU致皮质发育障碍模型具有癫易感性。 相似文献
98.
99.
100.
J S Lindholt S Juul H Fasting E W Henneberg 《European journal of vascular and endovascular surgery》2006,32(1):9-15
BACKGROUND: The aim of this study was to estimate the cost effectiveness of screening for abdominal aortic aneurysm (AAA). MATERIAL AND METHODS: All 12,639 men born in the years 1921-1933 (aged 64-73) living in Viborg County, Denmark, were randomly allocated either to receive an invitation to abdominal ultrasound scanning for AAA or to be controls. Costs for screening and surveillance were assessed prospectively. Diagnosis Related Group (DRG) costs from 1999 were used concerning admissions with uncomplicated and complicated operations. Admissions for AAA surgery were retrospectively classified according to complications in patient records. RESULTS: Mean follow-up time was 52 months. 76.6% of invited men attended screening, and 191 (4.0%) had an AAA. As previously reported, the cumulative 5-year AAA-specific mortality in the invited group was significantly reduced by 67% compared to the control group (P = 0.003). The costs were estimated to be Euro 11.23 per scan. The costs per life-year saved were Euro 9057 (Euro 5872-20,063) after 5 years, and were expected to decrease to Euro 2708 (Euro 1758-6031) after 10 years and to Euro 1825 (Euro 1185-4063) after 15 years. CONCLUSION: Screening of 64-73 years old males in Denmark seems cost effective. 相似文献